Product-specific advice (steroid nasal sprays) [Design Issues]

posted by Mikalai  – Belarus, 2018-10-16 15:42 (1693 d 22:03 ago) – Posting: # 19451
Views: 2,666

Dear friends,
Are there any explicit recommendations or guidelines from EMA about how to establish bio-equivalence for nasal sprays with steroids? More specifically, how can we avoid a therapeutic equivalence study, European approach? Are there any recommendations on Morphologically-Directed Raman Spectroscopy (MDRS) as a substitute for a therapeutic equivalence study? Any references will be appreciated.

Complete thread:

UA Flag
Activity
 Admin contact
22,617 posts in 4,740 threads, 1,611 registered users;
18 visitors (0 registered, 18 guests [including 8 identified bots]).
Forum time: 13:45 CEST (Europe/Vienna)

There are in fact two things, science and opinion;
the former begets knowledge, the latter ignorance.    Hippocrates

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5